News &amp; Updates

Patients with unstimulated thyroglobulin (Tg) ≤1 ng/mL or stimulated Tg ≤10 ng/mL who receive radioactive iodine therapy (RAIT) may benefit from a lower recurrence risk of intermediate-risk papillary thyroid cancer (PTC), reveals a study.

Hearing-impaired adults may ACHIEVE cognitive benefit from hearing aids

18 Aug 2023 by

Findings from the ACHIEVE* study suggest that older adults who are at increased risk for cognitive decline and dementia and who have hearing loss may benefit the most from hearing intervention within 3 years.

18 Aug 2023

Oral contraceptive use not linked to CVD, all-cause death in women

Women who use oral contraceptives do not have an excess risk of cardiovascular disease (CVD) events and all-cause death, with the contraceptives potentially conferring benefits to those who have used them for longer, according to a study.

Circumcision may reduce HIV risk in men who have sex with men

Voluntary medical male circumcision (VMMC) appears to cut the risk of contracting HIV infection among men who have sex with men (MSM), particularly those who mainly practice insertive anal sex, as shown in a study from China presented at IAS 2023.

Long-term hydrochlorothiazide use ups risk of skin cancer

Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.

17 Aug 2023

Social protection must include essential workers during pandemic: study

Essential workers, particularly at a Singapore hospital, have endured such a heavy burden during the COVID-19 pandemic, exposing themselves to risks of infections while putting up with increased workloads and workplace stress, longer hours in uncomfortable working conditions, as well as public stigmatization, results of a recent study show.

17 Aug 2023

Mohs micrographic surgery on par with wide local excision for Merkel cell carcinoma

Mohs micrographic surgery (MMS) as the surgical modality for primary cutaneous Merkel cell carcinoma (MCC) is not inferior to wide-local excision (WLE), showing no survival disadvantage, according to a recent study.

COVID-19 tied to in-hospital hyperglycaemia

A retrospective study combining ex vivo and in vitro assays showed an independent association between COVID-19 and the onset of hyperglycaemia.

17 Aug 2023

PPI exposure can make children susceptible to serious infections

The use of proton pump inhibitors (PPIs) appears to pose heightened risks of serious infections in young children, according to a study.

Relugolix combo reduces dysmenorrhea, NMPP in premenopausal women

The use of relugolix 40 mg in combination with oestradiol 1 mg and norethisterone acetate 0.5 mg (relugolix combination therapy [relugolix-CT]) significantly reduced dysmenorrhea and nonmenstrual pelvic pain (NMPP) in premenopausal women with endometriosis who received prior hormonal treatment, according to a post hoc analysis of two phase III trials presented at ESHRE 2023.